Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0636 CHF | +4.26% | +8.16% | +55.12% |
01/05 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
17/04 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+55.12% | 4.75M | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.40% | 31.87B | |
+51.96% | 24.52B | |
-14.35% | 15.68B | |
-39.65% | 12.23B | |
-6.52% | 12.34B | |
-13.41% | 12.21B | |
+5.17% | 8.83B |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Swiss Court OKs Moratorium Extension for Spexis